NewCardio, Inc.
NWCI
$0.00
$0.000.00%
OTC PK
| 09/30/2011 | 06/30/2011 | ||||
|---|---|---|---|---|---|
| Revenue | -90.26% | 159.85% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -90.26% | 159.85% | |||
| Cost of Revenue | -23.40% | -41.82% | |||
| Gross Profit | -126.83% | 390.27% | |||
| SG&A Expenses | -12.15% | -9.46% | |||
| Depreciation & Amortization | -0.84% | -3.25% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -14.59% | -8.60% | |||
| Operating Income | 10.16% | 11.94% | |||
| Income Before Tax | -143.67% | 61.27% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -143.67% | 61.27% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -143.67% | 61.27% | |||
| EBIT | 10.16% | 11.94% | |||
| EBITDA | 10.28% | 12.05% | |||
| EPS Basic | -141.38% | 63.06% | |||
| Normalized Basic EPS | -1,081.08% | 89.49% | |||
| EPS Diluted | -141.38% | 63.06% | |||
| Normalized Diluted EPS | -1,081.08% | 89.49% | |||
| Average Basic Shares Outstanding | 1.07% | 4.83% | |||
| Average Diluted Shares Outstanding | 1.07% | 4.83% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||